Key Metrics
- No. of Employees450
- Founded Year 2010
- Company StagePrivate Limited Company
- Total Funding₹970.19 Cr
- Industry
- Headquarter
- Company StatusActive
About Molbio
Molbio Diagnostics, brings to the healthcare professionals worldwide the "TruelabTM Real Time quantitative micro PCR system", that makes Real Time PCR testing simple and possible in all laboratories, in the field and in near-patient settings. The smart design of the hardware and the room temperature stable reagent microchip make the assay robust and affordable.
Business Model
Healthcare diagnostic firm Molbio Diagnostics’ flagship product Truenat provides real-time IoT-enabled testing kits for over 40 diseases in addition to TB, including COVID-19, hepatitis, HIV, HPV, and vector-borne diseases like dengue, chikungunya, and malaria.
Top Competitors
PR
PractoU72900KA2008PTC046374
3H
3hcareU85200DL2021PTC379169
PC
Pristyn CareU85300HR2018PTC075460
QU
Qure.aiU74999MH2016PTC283891
Molbio Funding Details
Funding Highlights
Latest Founding RoundPrivate Equity
Total Funding Raised₹970.19 Cr
No. of Investments Made0
Total No. of Acquisitions1
Lead Investors1
Investors
- Motilal Oswal
Funding Details
Funding History
Funding Per Year
Acquisition Company Done
Molbio Financial Details
Financial Highlights
FY 2022-23 Revenue₹337.41 Cr
FY 2022-23 Expenses₹327.87 Cr
FY 2022-23 Profit/Loss-₹3.44 Cr
Net Cash Flow From Operations₹64.13 Cr
Full Financial Details
Financial Comparison
Revenue Breakdown
Expense Breakdown
Shareholding Structure
Financial Ratio
Molbio Key People
People Metrics
Current Core Team1
Board Members/Directors5
Molbio Documents